These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 5880755)

  • 21. A double-blind study of prazosin in the treatment of Raynaud's phenomenon in scleroderma.
    Surwit RS; Gilgor RS; Allen LM; Duvic M
    Arch Dermatol; 1984 Mar; 120(3):329-31. PubMed ID: 6367665
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Scleroderma and Raynaud's phenomenon.
    BARNETT AJ
    Clin Rep; 1959; 9():33-74. PubMed ID: 13796900
    [No Abstract]   [Full Text] [Related]  

  • 23. Raynaud's Phenomenon: treatment of a severe case with biofeedback.
    Adair JR; Theobald DE
    J Indiana State Med Assoc; 1978 Oct; 71(10):990-3. PubMed ID: 701835
    [No Abstract]   [Full Text] [Related]  

  • 24. [CRST syndrome (calcinosis cutis--Raynaud's phenomenon--sclerodactylia--telangiectasis)].
    Ohm OJ
    Nord Med; 1970 Feb; 83(9):268-70. PubMed ID: 5426404
    [No Abstract]   [Full Text] [Related]  

  • 25. Raynaud's syndrome; acrosclerosis; scleroderma.
    JABLONSKA S; BUBNOW B; LUKASIAK B
    Br J Dermatol; 1958 Feb; 70(2):37-43. PubMed ID: 13510539
    [No Abstract]   [Full Text] [Related]  

  • 26. Generalized scleroderma with Raynaud's phenomena. Report of a case.
    Elmostehy MR; Bissada NF
    Egypt Dent J; 1970 Jan; 16(1):83-8. PubMed ID: 5268450
    [No Abstract]   [Full Text] [Related]  

  • 27. Plasma adrenomedullin and endothelin-1 levels are reduced and Raynaud's phenomenon improved by daily tadalafil administration in male patients with systemic sclerosis.
    Rosato E; Letizia C; Proietti M; Aversa A; Menghi G; Rossi C; Torella E; Cotesta D; Petramala L; Bruzziches R; Spera G; Pisarri S; Salsano F
    J Biol Regul Homeost Agents; 2009; 23(1):23-9. PubMed ID: 19321043
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of clonazepam on Raynaud's phenomenon and fingertip ulcers in scleroderma.
    Colakoğlu M; Cobankara V; Akpolat T
    Ann Pharmacother; 2007 Sep; 41(9):1544-7. PubMed ID: 17666574
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Raynaud's disease as a manifestation of generalized vascular disorders in systemic scleroderma].
    Guseva NG
    Kardiologiia; 1973 Oct; 13(10):76-82. PubMed ID: 4781474
    [No Abstract]   [Full Text] [Related]  

  • 30. [One stage parathyroidectomy and stellectomy for Raynaud's disease associated with scleroderma].
    ARMENIO S; VEGNI L
    Atti Accad Fisiocrit Siena Med Fis; 1955; 2():444-51. PubMed ID: 13341699
    [No Abstract]   [Full Text] [Related]  

  • 31. [Raynaud's syndrome: diagnosis and therapy].
    Mahler F
    Ther Umsch; 1985 Oct; 42(10):671-7. PubMed ID: 3909486
    [No Abstract]   [Full Text] [Related]  

  • 32. Scleroderma and raynaud's phenomenon improve with high-peak power laser therapy: a case report.
    St Surin-Lord S; Obagi S
    Dermatol Surg; 2011 Oct; 37(10):1531-5. PubMed ID: 21790846
    [No Abstract]   [Full Text] [Related]  

  • 33. Raynaud's phenomenon affecting the tongue of a patient with scleroderma.
    Bridges MJ; Kelly CA
    Ann Rheum Dis; 2002 May; 61(5):472. PubMed ID: 11959778
    [No Abstract]   [Full Text] [Related]  

  • 34. Efficacy evaluation of prostaglandin E1 against placebo in patients with progressive systemic sclerosis and significant Raynaud's phenomenon.
    Bartolone S; Trifiletti A; De Nuzzo G; Scamardi R; Larosa D; Sottilotta G; Raffa A; Barbera N
    Minerva Cardioangiol; 1999 May; 47(5):137-43. PubMed ID: 10479851
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Calcinosis, Raynaud's disease, slcerodactylia and telangiectasias in progressive systemic sclerosis. Statistic analysis of contingencies].
    Mintz G
    Gac Med Mex; 1974 Jun; 107(6):525-36. PubMed ID: 4448356
    [No Abstract]   [Full Text] [Related]  

  • 36. Digital arterial occlusion in scleroderma: is there a role for digital arterial reconstruction?
    Tomaino MM
    J Hand Surg Br; 2000 Dec; 25(6):611-3. PubMed ID: 11106531
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Raynaud's phenomenon, scleroderma, overlap syndromes, and other fibrosing syndromes.
    Clements PJ
    Curr Opin Rheumatol; 1993 Nov; 5(6):749-52. PubMed ID: 8117537
    [No Abstract]   [Full Text] [Related]  

  • 38. Raynaud's phenomenon with incomplete features of scleroderma: a wolf in sheep's clothing and a possible new indication for pulmonary/heart graft.
    Vayssairat M; Gouny P; Nussaume O
    Dermatology; 1994; 188(1):80. PubMed ID: 8305768
    [No Abstract]   [Full Text] [Related]  

  • 39. Transient global amnesia and Raynaud's phenomenon in scleroderma.
    Nishida A; Kaiya H; Uematsu M; Maeda M; Mori S; Wakabayashi S
    Acta Neurol Scand; 1990 Jun; 81(6):550-2. PubMed ID: 2220314
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Raynaud's phenomenon in limited cutaneous systemic sclerosis.
    Bonnecaze AK
    BMJ Case Rep; 2015 Dec; 2015():. PubMed ID: 26715139
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.